1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary

3.1. Market Outlook
3.2. Product Outlook
3.3. Mode of Delivery Outlook
3.4. Type of Animal Outlook
3.5. Competitor Outlook

4. Market Overview

4.1. Introduction

5. Market Dynamics

5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. United States Animal Antibiotics & Antimicrobials Market, By Product

6.1. Introduction
6.2. Aminoglycosides
6.3. Cephalosporins
6.4. Fluoroquinolones
6.5. Lincosamides
6.6. Macrolides
6.7. Penicillins
6.8. Sulfonamides
6.9. Tetracyclines

7. United States Animal Antibiotics & Antimicrobials Market, By Mode of Delivery

7.1. Introduction
7.2. Injections
7.3. Oral Powders
7.4. Oral Solutions
7.5. Premixes

8. United States Animal Antibiotics & Antimicrobials Market, By Type of Animal

8.1. Introduction
8.2. Companion Animals
8.2.1. Cats
8.2.2. Dogs
8.2.3. Horses
8.3. Food-Producing Animals
8.3.1. Cattle
8.3.2. Pigs
8.3.3. Poultry
8.3.4. Sheep and Goats

9. 360iResearch Competitive Strategic Window

9.1. Introduction
9.2. 360iResearch Competitive Strategic Window, by Product
9.3. 360iResearch Competitive Strategic Window, by Mode of Delivery
9.4. 360iResearch Competitive Strategic Window, by Type of Animal

10. Competitive Landscape

10.1. 360iResearch FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. 360iResearch Market Ranking Analysis
10.3. 360iResearch Market Share Analysis
10.4. 360iResearch Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion

11. Company Usability Profiles

11.1. Bayer AG
11.2. Boehringer Ingelheim GmbH
11.3. Eli Lilly and Company
11.4. Merck & Co., Inc.
11.5. Zoetis, Inc.

12. Appendix

12.1. Discussion Guide
12.2. Edition Details
12.3. License Details
12.4. Pricing Details

List of Figures

FIGURE 1. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
FIGURE 5. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2019 VS 2025 (USD MILLION)
FIGURE 6. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2019 VS 2025 (USD MILLION)
FIGURE 7. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, BY TYPE
FIGURE 8. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 9. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE GROWTH , 2017-2025 (USD MILLION)
FIGURE 10. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: MARKET DYNAMICS
FIGURE 11. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
FIGURE 12. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2019 VS 2025 (USD MILLION)
FIGURE 13. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2019 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2025
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2025
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2025
FIGURE 17. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 18. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS

List of Tables

TABLE 1. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CEPHALOSPORINS, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY LINCOSAMIDES, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2017-2025 (USD MILLION)
TABLE 7. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PENICILLINS, 2017-2025 (USD MILLION)
TABLE 8. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2017-2025 (USD MILLION)
TABLE 9. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2017-2025 (USD MILLION)
TABLE 10. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY INJECTIONS, 2017-2025 (USD MILLION)
TABLE 11. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL POWDERS, 2017-2025 (USD MILLION)
TABLE 12. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL SOLUTIONS, 2017-2025 (USD MILLION)
TABLE 13. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PREMIXES, 2017-2025 (USD MILLION)
TABLE 14. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2025 (USD MILLION)
TABLE 15. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATS, 2017-2025 (USD MILLION)
TABLE 16. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DOGS, 2017-2025 (USD MILLION)
TABLE 17. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY HORSES, 2017-2025 (USD MILLION)
TABLE 18. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2025 (USD MILLION)
TABLE 19. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATTLE, 2017-2025 (USD MILLION)
TABLE 20. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PIGS, 2017-2025 (USD MILLION)
TABLE 21. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POULTRY, 2017-2025 (USD MILLION)
TABLE 22. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SHEEP AND GOATS, 2017-2025 (USD MILLION)
TABLE 23. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: SCORES
TABLE 24. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: BUSINESS STRATEGY
TABLE 25. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: PRODUCT SATISFACTION
TABLE 26. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: RANKING
TABLE 27. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: MERGER & ACQUISITION
TABLE 28. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 29. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 30. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: INVESTMENT & FUNDING
TABLE 31. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 32. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: EDITION DETAILS
TABLE 33. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: LICENSE DETAILS
TABLE 34. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET: PRICING DETAILS

Companies Mentioned

Bayer AG
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck & Co., Inc.
Zoetis, Inc.